Reducing inappropriate prescribing for older adults with advanced frailty: A review based on a survey of practice in four countries

•Managing medications for people in advanced frailty is challenging; no clear consensus on inappropriate prescribing exists.•In this study, statins and bisphosphates were the most frequently deprescribed medications for people with advanced frailty.•Deprescribing instruments such as STOPPFrail can a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Maturitas 2019-08, Vol.126, p.1-10
Hauptverfasser: O’Caoimh, Rónán, Cornally, Nicola, McGlade, Ciara, Gao, Yang, O’Herlihy, Eileen, Svendrovski, Anton, Clarnette, Roger, Lavan, Amanda Hanora, Gallagher, Paul, William Molloy, D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10
container_issue
container_start_page 1
container_title Maturitas
container_volume 126
creator O’Caoimh, Rónán
Cornally, Nicola
McGlade, Ciara
Gao, Yang
O’Herlihy, Eileen
Svendrovski, Anton
Clarnette, Roger
Lavan, Amanda Hanora
Gallagher, Paul
William Molloy, D.
description •Managing medications for people in advanced frailty is challenging; no clear consensus on inappropriate prescribing exists.•In this study, statins and bisphosphates were the most frequently deprescribed medications for people with advanced frailty.•Deprescribing instruments such as STOPPFrail can assist with decision-making.•Clinician education plays an important role in deprescribing in advanced frailty. The management of medications in persons with frailty presents challenges. There is evidence of inappropriate prescribing and a lack of consensus among healthcare professionals on the judicious use of medications, particularly for patients with more severe frailty. This study reviews the evidence on the use of commonly prescribed pharmacological treatments in advanced frailty based on a questionnaire of prescribing practices and attitudes of healthcare professionals at different stages in their careers, in different countries. A convenience sample of those attending hospital grand rounds in Ireland, Canada and Australia/New Zealand (ANZ) were surveyed on the management of 18 medications in advanced frailty using a clinical vignette (man with severe dementia, Clinical Frailty Scale 7/9). Choices were to continue or discontinue (stop now or later) medications. In total, 298 respondents from Ireland (n = 124), Canada (n = 110), and ANZ (n = 64) completed the questionnaire, response rate 97%, including 81 consultants, 40 non-consultant hospital doctors, 134 general practitioners and 43 others (nurses, pharmacists, and medical students). Most felt that statins (88%), bisphosphonates (77%) and cholinesterase inhibitors (76%) should be discontinued. Thyroid replacement (88%), laxatives (83%) and paracetamol (81%) were most often continued. Respondents with experience in geriatric, palliative and dementia care were significantly more likely to discontinue medications. Age, gender and experience working in nursing homes did not contribute to the decision. Reflecting the current literature, there was no clear consensus on inappropriate prescribing, although respondents preferentially discontinued medications for secondary prevention. Experience significantly predicted the number and type discontinued, suggesting that education is important in reducing inappropriate prescribing for people in advanced states of frailty.
doi_str_mv 10.1016/j.maturitas.2019.04.212
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2310291167</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S037851221930132X</els_id><sourcerecordid>2310291167</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-1ab3073388201f3dea5d15df323dba55cac81096ba611bdab2f14a1a7ad6569d3</originalsourceid><addsrcrecordid>eNqFUctuFDEQtBCILAm_AD5ymcFtz2u5rSISIkVCQuRs9dg94NXsePFjoz3z43i1Idec2mpXV6mqGPsIogYB3edtvcOUg0sYaylgXYumliBfsRUMvaoaAHjNVkL1Q9WClBfsXYxbIUQrVPOWXSiQag0gVuzvD7LZuOUXdwvu98Hvg8NEfB8omuDG08_kA_ezpcDR5jlF_ujS7_I-4GLI8imgm9PxC9_wQAdHj3zEWPZ-4chjDgc6cj8VRjTJGSpChTEHbnxeUnAUr9ibCedI75_mJXu4-frz-lt1__327npzXxnVQ6oARyV6pYahOJ6UJWwttHZSUtkR29agGUCsuxE7gNHiKCdoELBH27Xd2qpL9unMW2z-yRST3rloaJ5xIZ-jlgqELLF0fYH2Z6gJPsZAky657DAcNQh9akBv9XMD-tSAFo0uDZTLD08iedyRfb77H3kBbM4AKlZLXEFH4-iUpAtkkrbevSjyD7Gjnrw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2310291167</pqid></control><display><type>article</type><title>Reducing inappropriate prescribing for older adults with advanced frailty: A review based on a survey of practice in four countries</title><source>Elsevier ScienceDirect Journals</source><creator>O’Caoimh, Rónán ; Cornally, Nicola ; McGlade, Ciara ; Gao, Yang ; O’Herlihy, Eileen ; Svendrovski, Anton ; Clarnette, Roger ; Lavan, Amanda Hanora ; Gallagher, Paul ; William Molloy, D.</creator><creatorcontrib>O’Caoimh, Rónán ; Cornally, Nicola ; McGlade, Ciara ; Gao, Yang ; O’Herlihy, Eileen ; Svendrovski, Anton ; Clarnette, Roger ; Lavan, Amanda Hanora ; Gallagher, Paul ; William Molloy, D.</creatorcontrib><description>•Managing medications for people in advanced frailty is challenging; no clear consensus on inappropriate prescribing exists.•In this study, statins and bisphosphates were the most frequently deprescribed medications for people with advanced frailty.•Deprescribing instruments such as STOPPFrail can assist with decision-making.•Clinician education plays an important role in deprescribing in advanced frailty. The management of medications in persons with frailty presents challenges. There is evidence of inappropriate prescribing and a lack of consensus among healthcare professionals on the judicious use of medications, particularly for patients with more severe frailty. This study reviews the evidence on the use of commonly prescribed pharmacological treatments in advanced frailty based on a questionnaire of prescribing practices and attitudes of healthcare professionals at different stages in their careers, in different countries. A convenience sample of those attending hospital grand rounds in Ireland, Canada and Australia/New Zealand (ANZ) were surveyed on the management of 18 medications in advanced frailty using a clinical vignette (man with severe dementia, Clinical Frailty Scale 7/9). Choices were to continue or discontinue (stop now or later) medications. In total, 298 respondents from Ireland (n = 124), Canada (n = 110), and ANZ (n = 64) completed the questionnaire, response rate 97%, including 81 consultants, 40 non-consultant hospital doctors, 134 general practitioners and 43 others (nurses, pharmacists, and medical students). Most felt that statins (88%), bisphosphonates (77%) and cholinesterase inhibitors (76%) should be discontinued. Thyroid replacement (88%), laxatives (83%) and paracetamol (81%) were most often continued. Respondents with experience in geriatric, palliative and dementia care were significantly more likely to discontinue medications. Age, gender and experience working in nursing homes did not contribute to the decision. Reflecting the current literature, there was no clear consensus on inappropriate prescribing, although respondents preferentially discontinued medications for secondary prevention. Experience significantly predicted the number and type discontinued, suggesting that education is important in reducing inappropriate prescribing for people in advanced states of frailty.</description><identifier>ISSN: 0378-5122</identifier><identifier>EISSN: 1873-4111</identifier><identifier>DOI: 10.1016/j.maturitas.2019.04.212</identifier><identifier>PMID: 31239110</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Deprescribing ; Frailty ; Inappropriate prescribing ; Multi-morbidity ; Polypharmacy ; Systematic review</subject><ispartof>Maturitas, 2019-08, Vol.126, p.1-10</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-1ab3073388201f3dea5d15df323dba55cac81096ba611bdab2f14a1a7ad6569d3</citedby><cites>FETCH-LOGICAL-c371t-1ab3073388201f3dea5d15df323dba55cac81096ba611bdab2f14a1a7ad6569d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S037851221930132X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31239110$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O’Caoimh, Rónán</creatorcontrib><creatorcontrib>Cornally, Nicola</creatorcontrib><creatorcontrib>McGlade, Ciara</creatorcontrib><creatorcontrib>Gao, Yang</creatorcontrib><creatorcontrib>O’Herlihy, Eileen</creatorcontrib><creatorcontrib>Svendrovski, Anton</creatorcontrib><creatorcontrib>Clarnette, Roger</creatorcontrib><creatorcontrib>Lavan, Amanda Hanora</creatorcontrib><creatorcontrib>Gallagher, Paul</creatorcontrib><creatorcontrib>William Molloy, D.</creatorcontrib><title>Reducing inappropriate prescribing for older adults with advanced frailty: A review based on a survey of practice in four countries</title><title>Maturitas</title><addtitle>Maturitas</addtitle><description>•Managing medications for people in advanced frailty is challenging; no clear consensus on inappropriate prescribing exists.•In this study, statins and bisphosphates were the most frequently deprescribed medications for people with advanced frailty.•Deprescribing instruments such as STOPPFrail can assist with decision-making.•Clinician education plays an important role in deprescribing in advanced frailty. The management of medications in persons with frailty presents challenges. There is evidence of inappropriate prescribing and a lack of consensus among healthcare professionals on the judicious use of medications, particularly for patients with more severe frailty. This study reviews the evidence on the use of commonly prescribed pharmacological treatments in advanced frailty based on a questionnaire of prescribing practices and attitudes of healthcare professionals at different stages in their careers, in different countries. A convenience sample of those attending hospital grand rounds in Ireland, Canada and Australia/New Zealand (ANZ) were surveyed on the management of 18 medications in advanced frailty using a clinical vignette (man with severe dementia, Clinical Frailty Scale 7/9). Choices were to continue or discontinue (stop now or later) medications. In total, 298 respondents from Ireland (n = 124), Canada (n = 110), and ANZ (n = 64) completed the questionnaire, response rate 97%, including 81 consultants, 40 non-consultant hospital doctors, 134 general practitioners and 43 others (nurses, pharmacists, and medical students). Most felt that statins (88%), bisphosphonates (77%) and cholinesterase inhibitors (76%) should be discontinued. Thyroid replacement (88%), laxatives (83%) and paracetamol (81%) were most often continued. Respondents with experience in geriatric, palliative and dementia care were significantly more likely to discontinue medications. Age, gender and experience working in nursing homes did not contribute to the decision. Reflecting the current literature, there was no clear consensus on inappropriate prescribing, although respondents preferentially discontinued medications for secondary prevention. Experience significantly predicted the number and type discontinued, suggesting that education is important in reducing inappropriate prescribing for people in advanced states of frailty.</description><subject>Deprescribing</subject><subject>Frailty</subject><subject>Inappropriate prescribing</subject><subject>Multi-morbidity</subject><subject>Polypharmacy</subject><subject>Systematic review</subject><issn>0378-5122</issn><issn>1873-4111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFUctuFDEQtBCILAm_AD5ymcFtz2u5rSISIkVCQuRs9dg94NXsePFjoz3z43i1Idec2mpXV6mqGPsIogYB3edtvcOUg0sYaylgXYumliBfsRUMvaoaAHjNVkL1Q9WClBfsXYxbIUQrVPOWXSiQag0gVuzvD7LZuOUXdwvu98Hvg8NEfB8omuDG08_kA_ezpcDR5jlF_ujS7_I-4GLI8imgm9PxC9_wQAdHj3zEWPZ-4chjDgc6cj8VRjTJGSpChTEHbnxeUnAUr9ibCedI75_mJXu4-frz-lt1__327npzXxnVQ6oARyV6pYahOJ6UJWwttHZSUtkR29agGUCsuxE7gNHiKCdoELBH27Xd2qpL9unMW2z-yRST3rloaJ5xIZ-jlgqELLF0fYH2Z6gJPsZAky657DAcNQh9akBv9XMD-tSAFo0uDZTLD08iedyRfb77H3kBbM4AKlZLXEFH4-iUpAtkkrbevSjyD7Gjnrw</recordid><startdate>201908</startdate><enddate>201908</enddate><creator>O’Caoimh, Rónán</creator><creator>Cornally, Nicola</creator><creator>McGlade, Ciara</creator><creator>Gao, Yang</creator><creator>O’Herlihy, Eileen</creator><creator>Svendrovski, Anton</creator><creator>Clarnette, Roger</creator><creator>Lavan, Amanda Hanora</creator><creator>Gallagher, Paul</creator><creator>William Molloy, D.</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201908</creationdate><title>Reducing inappropriate prescribing for older adults with advanced frailty: A review based on a survey of practice in four countries</title><author>O’Caoimh, Rónán ; Cornally, Nicola ; McGlade, Ciara ; Gao, Yang ; O’Herlihy, Eileen ; Svendrovski, Anton ; Clarnette, Roger ; Lavan, Amanda Hanora ; Gallagher, Paul ; William Molloy, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-1ab3073388201f3dea5d15df323dba55cac81096ba611bdab2f14a1a7ad6569d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Deprescribing</topic><topic>Frailty</topic><topic>Inappropriate prescribing</topic><topic>Multi-morbidity</topic><topic>Polypharmacy</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O’Caoimh, Rónán</creatorcontrib><creatorcontrib>Cornally, Nicola</creatorcontrib><creatorcontrib>McGlade, Ciara</creatorcontrib><creatorcontrib>Gao, Yang</creatorcontrib><creatorcontrib>O’Herlihy, Eileen</creatorcontrib><creatorcontrib>Svendrovski, Anton</creatorcontrib><creatorcontrib>Clarnette, Roger</creatorcontrib><creatorcontrib>Lavan, Amanda Hanora</creatorcontrib><creatorcontrib>Gallagher, Paul</creatorcontrib><creatorcontrib>William Molloy, D.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Maturitas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O’Caoimh, Rónán</au><au>Cornally, Nicola</au><au>McGlade, Ciara</au><au>Gao, Yang</au><au>O’Herlihy, Eileen</au><au>Svendrovski, Anton</au><au>Clarnette, Roger</au><au>Lavan, Amanda Hanora</au><au>Gallagher, Paul</au><au>William Molloy, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reducing inappropriate prescribing for older adults with advanced frailty: A review based on a survey of practice in four countries</atitle><jtitle>Maturitas</jtitle><addtitle>Maturitas</addtitle><date>2019-08</date><risdate>2019</risdate><volume>126</volume><spage>1</spage><epage>10</epage><pages>1-10</pages><issn>0378-5122</issn><eissn>1873-4111</eissn><abstract>•Managing medications for people in advanced frailty is challenging; no clear consensus on inappropriate prescribing exists.•In this study, statins and bisphosphates were the most frequently deprescribed medications for people with advanced frailty.•Deprescribing instruments such as STOPPFrail can assist with decision-making.•Clinician education plays an important role in deprescribing in advanced frailty. The management of medications in persons with frailty presents challenges. There is evidence of inappropriate prescribing and a lack of consensus among healthcare professionals on the judicious use of medications, particularly for patients with more severe frailty. This study reviews the evidence on the use of commonly prescribed pharmacological treatments in advanced frailty based on a questionnaire of prescribing practices and attitudes of healthcare professionals at different stages in their careers, in different countries. A convenience sample of those attending hospital grand rounds in Ireland, Canada and Australia/New Zealand (ANZ) were surveyed on the management of 18 medications in advanced frailty using a clinical vignette (man with severe dementia, Clinical Frailty Scale 7/9). Choices were to continue or discontinue (stop now or later) medications. In total, 298 respondents from Ireland (n = 124), Canada (n = 110), and ANZ (n = 64) completed the questionnaire, response rate 97%, including 81 consultants, 40 non-consultant hospital doctors, 134 general practitioners and 43 others (nurses, pharmacists, and medical students). Most felt that statins (88%), bisphosphonates (77%) and cholinesterase inhibitors (76%) should be discontinued. Thyroid replacement (88%), laxatives (83%) and paracetamol (81%) were most often continued. Respondents with experience in geriatric, palliative and dementia care were significantly more likely to discontinue medications. Age, gender and experience working in nursing homes did not contribute to the decision. Reflecting the current literature, there was no clear consensus on inappropriate prescribing, although respondents preferentially discontinued medications for secondary prevention. Experience significantly predicted the number and type discontinued, suggesting that education is important in reducing inappropriate prescribing for people in advanced states of frailty.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>31239110</pmid><doi>10.1016/j.maturitas.2019.04.212</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5122
ispartof Maturitas, 2019-08, Vol.126, p.1-10
issn 0378-5122
1873-4111
language eng
recordid cdi_proquest_miscellaneous_2310291167
source Elsevier ScienceDirect Journals
subjects Deprescribing
Frailty
Inappropriate prescribing
Multi-morbidity
Polypharmacy
Systematic review
title Reducing inappropriate prescribing for older adults with advanced frailty: A review based on a survey of practice in four countries
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T04%3A52%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reducing%20inappropriate%20prescribing%20for%20older%20adults%20with%20advanced%20frailty:%20A%20review%20based%20on%20a%20survey%20of%20practice%20in%20four%20countries&rft.jtitle=Maturitas&rft.au=O%E2%80%99Caoimh,%20R%C3%B3n%C3%A1n&rft.date=2019-08&rft.volume=126&rft.spage=1&rft.epage=10&rft.pages=1-10&rft.issn=0378-5122&rft.eissn=1873-4111&rft_id=info:doi/10.1016/j.maturitas.2019.04.212&rft_dat=%3Cproquest_cross%3E2310291167%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2310291167&rft_id=info:pmid/31239110&rft_els_id=S037851221930132X&rfr_iscdi=true